Even Mild Covid Is Linked To Higher Risk of Deadly Blood Clots: Study

Even Mild Covid Is Linked To Higher Risk of Deadly Blood Clots: Study
Fecha de publicación: 
26 October 2022
Imagen principal: 

Covid-19 at any level of severity is linked to an increased risk of dangerous blood clots that start in patients' veins and travel to the heart, lungs and other parts of the body, according to a UK study that highlights the pandemic's role in driving up rates of cardiovascular disease.

Non-hospitalised Covid patients were 2.7 times more likely to develop dangerous clots called venous thromboembolisms and were more than 10 times more likely to die than individuals who avoided the disease, scientists at Queen Mary University of London found in a study of almost 54,000 people followed for an average of about 4 1/2 months. The increase in risk was highest in the first 30 days after the disease began, but could remain elevated even longer, the researchers said.

The findings are yet another sign of the hidden dangers of the virus that can result even from mild cases. Yet risks were significantly worse for patients hospitalised for Covid, who had 28 times higher risk of venous thromboembolism, 22 times increased risk of heart failure and 18 times greater risk of stroke than unaffected people. Their chance of dying was 118-fold higher compared with their uninfected counterparts.

The research, based on data collected during the country's first two Covid waves from participants in the UK Biobank study, was published Monday in the journal Heart. It adds to evidence of Covid's propensity to damage blood vessels and cause life-threatening clots, especially early in the infection.

"Our findings highlight the increased cardiovascular risk of individuals with past infection, which are likely to be greater in countries with limited access to vaccination and thus greater population exposure to Covid-19," Zahra Raisi-Estabragh, a clinical research training fellow at Queen Mary, and co-authors wrote. "Further research is required to delineate the period over which the augmented cardiovascular risk persists."

Add new comment

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Enter the characters shown in the image.